Wikidata entity: Q958087
C₁₉H₂₄N₂O₃ (P274)
Quantities
| P2067 | mass | 328.178693 |
| P3780 | active ingredient in | ... | Q47521750 (Trandate) | Trandate |
| P233 | canonical SMILES | String | CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O | ??? |
| P373 | Commons category | String | Labetalol | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P8026 | LiverTox likelihood score | ... | Q83284310 (LiverTox toxicity likelihood category C) | LiverTox toxicity likelihood category C |
| P2175 | medical condition treated | ... | Q12152 (myocardial infarction) | myocardial infarction |
| P2175 | medical condition treated | ... | Q41861 (arterial hypertension) | arterial hypertension |
| P2175 | medical condition treated | ... | Q180762 (angina pectoris) | angina pectoris |
| P2175 | medical condition treated | ... | Q1641132 (malignant hypertension) | malignant hypertension |
| P2175 | medical condition treated | ... | Q19000661 (congestive heart failure) | congestive heart failure |
| P129 | physically interacts with | ... | Q287958 (Adrenoceptor beta 1) | Adrenoceptor beta 1 |
| P129 | physically interacts with | ... | Q287961 (adrenoceptor beta 2) | adrenoceptor beta 2 |
| P129 | physically interacts with | ... | Q4734887 (Adrenoceptor alpha 1D) | Adrenoceptor alpha 1D |
| P769 | significant drug interaction | ... | Q58396 (imipramine) | imipramine |
| P769 | significant drug interaction | ... | Q412221 (clonidine) | clonidine |
| P769 | significant drug interaction | ... | Q412621 (methyldopa) | methyldopa |
| P769 | significant drug interaction | ... | Q410061 (amiodarone) | amiodarone |
| P769 | significant drug interaction | ... | Q410291 (verapamil) | verapamil |
| P769 | significant drug interaction | ... | Q411887 (rivastigmine) | rivastigmine |
| P769 | significant drug interaction | ... | Q413918 (isoflurane) | isoflurane |
| P769 | significant drug interaction | ... | Q418480 (tamsulosin) | tamsulosin |
| P769 | significant drug interaction | ... | Q419939 (doxazosin) | doxazosin |
| P769 | significant drug interaction | ... | Q280786 (terazosin) | terazosin |
| P769 | significant drug interaction | ... | Q408637 (dronedarone) | dronedarone |
| P769 | significant drug interaction | ... | Q2736873 (alfuzosin) | alfuzosin |
| P769 | significant drug interaction | ... | Q5186964 (crizotinib) | crizotinib |
| P769 | significant drug interaction | ... | Q419944 (moxonidine) | moxonidine |
| P769 | significant drug interaction | ... | Q422222 (digoxin) | digoxin |
| P769 | significant drug interaction | ... | Q422229 (diltiazem) | diltiazem |
| P769 | significant drug interaction | ... | Q425137 (fingolimod) | fingolimod |
| P769 | significant drug interaction | ... | Q425296 (prazosin) | prazosin |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q598405 (sympathomimetic drug) | sympathomimetic drug |
| P2868 | subject has role | ... | Q816759 (beta blocker) | beta blocker |
| P2868 | subject has role | ... | Q50430371 (adrenergic alpha-1 receptor antagonists) | adrenergic alpha-1 receptor antagonists |
| P2868 | subject has role | ... | Q575890 (antihypertensive drug) | antihypertensive drug |
Why not click here or view trends?
log id: 2086285